Serum RIPK3/MLKL as exploratory biomarker candidates for systemic lupus erythematosus
Lupus: An International Journal
Published online on June 24, 2026
Abstract
Lupus, Ahead of Print.
ObjectiveThis study aims to elucidate the novel role of serum receptor interacting protein kinase 3 (RIPK3)/mixed series of protein kinase-like domains (MLKL) levels in SLE and assess their correlation with clinical manifestations and serological ...
ObjectiveThis study aims to elucidate the novel role of serum receptor interacting protein kinase 3 (RIPK3)/mixed series of protein kinase-like domains (MLKL) levels in SLE and assess their correlation with clinical manifestations and serological ...